Not applicableEnded earlyNCT02483416What this trial is testingEvaluation of the Impact of Nurse-led Telephone on Treatment ComplianceWho this might be right forCarcinoma, Non-Small-Cell Lung Boehringer Ingelheim 30
Early research (Phase 1)Study completedNCT00903734What this trial is testingAn Umbrella, Modular Study Based on Epidermal Growth Factor Receptor (EGFR) Mutation StatusWho this might be right forAdvanced Cancers M.D. Anderson Cancer Center 16
Testing effectiveness (Phase 2)UnknownNCT01714908What this trial is testingPhase II Study of Erlotinib With Concurrent Radiotherapy in Unresectable NSCLC With Activating Mutation of EGFR in Exon 19 or 21Who this might be right forNon-small Cell Lung Cancer Jinming Yu 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT06194448What this trial is testingTo Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR MutationsWho this might be right forLung Cancer AstraZeneca 76
Early research (Phase 1)Study completedNCT04959981What this trial is testingAnti-Cancer Therapies Targeting the MAPK Pathway in Patients With Advanced NSCLCWho this might be right forAdvanced Non-squamous Non-small-cell Lung Cancer Erasca, Inc. 24
Not applicableStudy completedNCT03562819What this trial is testingStudy to Evaluate Concordance of Detecting EGFR (Epidermal Growth Factor Receptor) Mutation by Circulating Tumour Free DNA Versus Tissues Biopsy in NSCLC (Non-small Cell Lung Cancer).Who this might be right forNSCLC (Non-small Cell Lung Cancer) AstraZeneca 268
Not applicableStudy completedNCT02991274What this trial is testingARTEMIS DIANE T790M (An Amino Acid Substitution at Position 790 in EGFR, From a Threonine (T) to a Methionine (M)) Mutation at Hospital Laboratories in Comparison With Central LaboratoryWho this might be right forLocally Advanced or Metastatic EGFR(+) NSCLC Patients AstraZeneca 897
Large-scale testing (Phase 3)Active Not RecruitingNCT04351555What this trial is testingOsimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer AstraZeneca 358
Testing effectiveness (Phase 2)UnknownNCT03062800What this trial is testingStudy of Thalidomide in Treatment of Advanced Nsclc (Dream-003)Who this might be right forAdvanced Nsclc Qilu Hospital of Shandong University 232
Not applicableUnknownNCT01697163What this trial is testingDe Novo Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase InhibitorsWho this might be right forNSCLC Severance Hospital 155
Testing effectiveness (Phase 2)Looking for participantsNCT06071013What this trial is testingNintedanib Plus EGFR TKI In EGFR-mutated Non-small Cell Lung Cancer PatientsWho this might be right forNon-small Cell Lung CancerEGFR Gene MutationEGFR-TKI Resistant Mutation China Medical University Hospital 20
Early research (Phase 1)Looking for participantsNCT04085315What this trial is testingAlisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung CancerWho this might be right forLung Cancer MetastaticEGFR Gene Mutation Collin Blakely 38
Testing effectiveness (Phase 2)UnknownNCT04470076What this trial is testingNeoadjuvant Afatinib Combination With Chemotherapy for Stage Ⅱa-Ⅲb NSCLC With EGFR Activating MutationWho this might be right forNon Small Cell Lung CancerSurgeryEGFR Activating Mutation+2 more Fifth Affiliated Hospital, Sun Yat-Sen University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06300424What this trial is testingNeoadjuvant Almonertinib Followed by Chemo-immunotherapy in II-IIIB EGFR-mutant NSCLCWho this might be right forNon Small Cell Lung CancerEGFR Gene Mutation Guangdong Provincial People's Hospital 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06018688What this trial is testingOsimertinib Combined With Aspirin Neoadjuvant Therapy for Resectable EGFR Mutated NSCLC Patients.Who this might be right forNon Small Cell Lung CancerEGFR Gene Mutation Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 44
Not applicableUnknownNCT06095934What this trial is testingEfficacy and Safety of Neoantigen Peptide Vaccine in the Treatment of Advanced NSCLC Progressed After EGFR-TKI TreatmentWho this might be right forNSCLCEGFR Gene Mutation The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 20
Not applicableLooking for participantsNCT06304441What this trial is testingIntra-pemetrexed Plus Third-generation Small Molecule TKI Drugs (e.g. 'Osimertinib') Versus Third-generation Small Molecule TKI Drugs Alone for Leptomeningeal Metastasis From Epidermal Growth Factor Receptor Mutation-Positive Non-Small-cell Lung CancerWho this might be right forLeptomeningeal Metastasis Guangzhou Medical University 100
Early research (Phase 1)Ended earlyNCT05153408What this trial is testing(HARMONY) Study of BLU-701 in EGFR-mutant NSCLCWho this might be right forLung NeoplasmCarcinoma, Non-Small-Cell LungRespiratory Tract Neoplasms+24 more Blueprint Medicines Corporation 20
Not applicableUnknownNCT06207292What this trial is testingStereotactic Ablative Radiotherapy in Synchronous and Metachronous Oligo-Metastatic Non Small Cell Lung CancerWho this might be right forNSCLCNSCLC Stage IVOligometastatic Disease+9 more Radiotherapy Oncology Centre "Santa Maria" Hospital 100
Large-scale testing (Phase 3)Looking for participantsNCT06970639What this trial is testingA Study Evaluating Furmonertinib Plus Platinum-based Doublet Chemotherapy Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Sensitizing Mutation-Positive Non-squamous Non-Small Cell Lung Cancer (NSCLC) and Brain MetastasesWho this might be right forNSCLC Patients With Brain Metastasis Allist Pharmaceuticals, Inc. 380